Medroxyprogesterone
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Medroxyprogesterone, covering 2012-09-26 to 2014-09-23. Get the full timeline:
Most recent: Clinical Trial Update: Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer [Phase 2]